A model for improving the treatment and care of Alzheimer's disease patients through interdisciplinary research

Alzheimer's and Dementia

Volumn 8, Issue 6, 2012, Pages 564-573

  Trojanowski, John Q ^a,b   Arnold, Steven E ^a,b   Karlawish, Jason H ^a,c   Naylor, Mary ^a,b   Brunden, Kurt R ^a,b   Lee, Virginia M Y ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Alzheimer's disease; Biomarkers; Clinical trial design; Continuity of care; Drug discovery

Indexed keywords

THROMBOXANE RECEPTOR BLOCKING AGENT;

ALZHEIMER DISEASE; CLINICAL RESEARCH; COGNITION; COGNITIVE DEFECT; HEALTH CARE COST; HEALTH CARE QUALITY; HUMAN; INTERDISCIPLINARY RESEARCH; MICROTUBULE; NONHUMAN; PATIENT CARE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW;

EID: 84867891361     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2011.08.005     Document Type: Article

References (53)

1. Alzheimer's Association Alzheimer's disease facts and figures Alzheimers Dement 6 2010 158 194
2. L.E. Hebert, L.A. Beckett, P.A. Scherr, and D.A. Evans Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050 Alzheimer Dis Assoc Disord 15 2001 169 173
3. Z.S. Khachaturian, P.J. Snyder, R. Doody, P. Aisen, M. Comer, J. Dwyer, R.A. Frank, A. Holzapfel, A.S. Khachaturian, and A.D. Korczyn A roadmap for the prevention of dementia II: Leon Thal Symposium 2008 Alzheimers Dement 5 2009 85 92
4. B.L. Plassman, K.M. Langa, G.G. Fisher, S.G. Heeringa, D.R. Weir, M.B. Ofstedal, J.R. Burke, M.D. Hurd, G.G. Potter, and W.L. Rodgers Prevalence of dementia in the United States: the aging, demographics, and memory study Neuroepidemiology 29 2007 125 132
5. The Alzheimer's Study Group. A national Alzheimer's strategic plan: the report of the Alzheimer's Study Group. Available at: www.alz.org/news-and- events-16243.asp); 2008.
6. Wimo A, Prince M. Alzheimer's Disease International world Alzheimer report 2010 - the global economic impact of dementia. Available at: http://www.alz.org/documents/national/World-Alzheimer-Report-2010.pdf; 2010.
7. K.G. Manton Recent declines in chronic disability in the elderly U.S. population: risk factors and future dynamics Annu Rev Public Health 29 2008 91 113
8. R. Brookmeyer, S. Gray, and C. Kawas Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset Am J Public Health 88 1997 1337 1342
9. K.R. Brunden, J.Q. Trojanowski, and V.M. Lee Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies Nat Rev Drug Discov 8 2009 783 793
10. J.L. Price, and J.C. Morris Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease Ann Neurol 45 1999 358 368
11. J.A. Schneider, Z. Arvanitakis, W. Bang, and D.A. Bennett Mixed brain pathologies account for most dementia cases in community-dwelling older persons Neurology 69 2007 2197 2204
12. R.D. Terry, E. Masliah, D.P. Salmon, N. Butters, R. DeTeresa, R. Hill, L.A. Hansen, and R. Katzman Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment Ann Neurol 30 1991 572 580
13. L. White, B.J. Small, H. Petrovitch, G.W. Ross, K. Masaki, R.D. Abbott, J. Hardman, D. Davis, J. Nelson, and W. Markesbery Recent clinical-pathologic research on the causes of dementia in late life: update from the Honolulu-Asia Aging Study J Geriatr Psychiatry Neurol 18 2005 224 227
14. T. Gomez-Isla, R. Hollister, H. West, S. Mui, J.H. Growdon, R.C. Petersen, J.E. Parisi, and B.T. Hyman Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease Ann Neurol 41 1997 17 24
15. G.M. Savva, S.B. Wharton, P.G. Ince, G. Forster, F.E. Matthews, and C. Brayne Age, neuropathology, and dementia N Engl J Med 360 2009 2302 2309
16. P.S. Aisen, R.C. Petersen, M. Donohue, A. Gamst, R. Raman, R.G. Thomas, S. Walter, J.Q. Trojanowski, L. Shaw, and L.A. Beckett Clinical core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans Alzheimers Dement 6 2010 239 246
17. B. Dubois, H.H. Feldman, C. Jacova, J.L. Cummings, S.T. Dekosky, P. Barberger-Gateau, A. Delacourte, G. Frisoni, N.C. Fox, and D. Galasko Revising the definition of Alzheimer's disease: a new lexicon Lancet Neurol 9 2010 1118 1127
18. C.R. Jack Jr., D.S. Knopman, W.J. Jagust, L.M. Shaw, P.S. Aisen, M.W. Weiner, R.C. Petersen, and J.Q. Trojanowski Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade Lancet Neurol 9 2010 119 128
19. D.S. Knopman, J.E. Parisi, A. Salviati, M. Floriach-Robert, B.F. Boeve, R.J. Ivnik, G.E. Smith, D.W. Dickson, K.A. Johnson, and L.E. Petersen Neuropathology of cognitively normal elderly J Neuropathol Exp Neurol 62 2003 1087 1095
20. Hampel H, Wilcock G, Andrieu S, Aisen P, Blennow K, Broich K, Carrillo M, Fox NC, Frisoni GB, Isaac M, et al. Biomarkers for Alzheimer's disease therapeutic trials. Prog Neurobiol (in press).
21. J.Q. Trojanowski, H. Vandeerstichele, M. Korecka, C.M. Clark, P.S. Aisen, R.C. Petersen, K. Blennow, H. Soares, A. Simon, and P. Lewczuk Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects Alzheimers Dement 6 2010 230 238
22. M.W. Weiner, P.S. Aisen, C.R. Jack Jr., W.J. Jagust, J.Q. Trojanowski, L. Shaw, A.J. Saykin, J.C. Morris, N. Cairns, and L.A. Beckett The Alzheimer's disease neuroimaging initiative: progress report and future plans Alzheimers Dement 6 2010 202-11.e7
23. Alzheimer's Association. Characteristics, costs and health service use for Medicare beneficiaries with a dementia diagnosis. Report 1: Medicare current beneficiary survey. Prepared under contract by Julie Bynum, M.D., MPH, Dartmouth Institute for Health Policy and Clinical Care, Center for Health Policy Research. 2009.
24. J.L. Rudolph, N.M. Zanin, R.N. Jones, E.R. Marcantonio, T.G. Fong, F.M. Yang, L. Yap, and S.K. Inouye Hospitalization in community-dwelling persons with Alzheimer's disease: frequency and causes J Am Geriatr Soc 58 2010 1542 1548
25. M. Naylor, and J. Van Cleave The Transitional Care Model for older adults A.I. Meleis, Transitions Theory: Middle Range and Situation Specific Theories in Research and Practice 2010 Springer Publishing Company New York, NY
26. E.A. Mellon, D.T. Pilkinton, C.M. Clark, M.A. Elliott, W.R. Witschey 2nd, A. Borthakur, and R. Reddy Sodium MR imaging detection of mild Alzheimer disease: preliminary study AJNR Am J Neuroradiol 30 2009 978 984
27. M.D. Naylor, D. Brooten, R. Campbell, B.S. Jacobsen, M.D. Mezey, M.V. Pauly, and J.S. Schwartz Comprehensive discharge planning and home follow-up of hospitalized elders: a randomized clinical trial JAMA 281 1999 613 620
28. M.D. Naylor, D.A. Brooten, R.L. Campbell, G. Maislin, K.M. McCauley, and J.S. Schwartz Transitional care of older adults hospitalized with heart failure: a randomized, controlled trial J Am Geriatr Soc 52 2004 675 684
29. M. Naylor, D. Brooten, R. Jones, R. Lavizzo-Mourey, M. Mezey, and M. Pauly Comprehensive discharge planning for the hospitalized elderly. A randomized clinical trial Ann Intern Med 120 1994 999 1006
30. M.D. Naylor, K.B. Hirschman, K.H. Bowles, M.B. Bixby, J. Konick-McMahan, and C. Stephens Care coordination for cognitively impaired older adults and their caregivers Home Health Care Serv Q 26 2007 57 78
31. K.B. Hirschman, H.H. Paik, J.B. Pines, C. McCusker, M.D. Naylor, and J.E. Hollander Cognitive impairment among older adults in the Emergency Department West J Emerg Med 12 2011 56 62
32. Hirschman KB, Abbott KM, Hanlon AL, Prvu Gettger J, Naylor MD. Advance care planning among elders receiving long-term care services. Am Med Dir Assoc (in press).
33. M.G. Livney, C.M. Clark, J.H. Karlawish, S. Cartmell, M. Negron, J. Nunez-Lopez, I.E. Vega, F. Entenza-Cabrera, and S.E. Arnold Ethnoracial differences in the clinical presentation of Alzheimer's disease at an urban Alzheimer's disease center Am J Geriatr Psychiatry 19 2011 430 439
34. G. De Meyer, F. Shapiro, H. Vanderstichele, E. Vanmechelen, S. Engelborghs, P.P. De Deyn, E. Coart, O. Hansson, L. Minthon, and H. Zetterberg Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people Arch Neurol 67 2010 949 956
35. W.T. Hu, A. Chen-Plotkin, S.E. Arnold, M. Grossman, C.M. Clark, L.M. Shaw, L. McCluskey, L. Elman, J. Karlawish, and H.I. Hurtig Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease Acta Neuropathol 120 2010 385 399
36. W.T. Hu, A. Chen-Plotkin, S.E. Arnold, M. Grossman, C.M. Clark, L.M. Shaw, E. Pickering, M. Kuhn, Y. Chen, and L. McCluskey Novel CSF biomarkers for Alzheimer's disease and mild cognitive impairment Acta Neuropathol 119 2010 669 678
37. L.M. Shaw, H. Vanderstichele, M. Knapik-Czajka, C.M. Clark, P.S. Aisen, R.C. Petersen, K. Blennow, H. Soares, A. Simon, and P. Lewczuk Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects Ann Neurol 65 2009 403 413
38. S. Negash, D.A. Bennett, R.S. Wilson, J.A. Schneider, and S.E. Arnold Cognition and neuropathology in aging: multidimensional perspectives from the Rush Religious Orders Study and Rush Memory and Aging Project Curr Alzheimer Res 8 2011 336 340
39. C. Davatzikos, P. Bhatt, L.M. Shaw, K.N. Batmanghelich, and J.Q. Trojanowski Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification Neurobiol Aging 32 2010 2322.e19 2322.e27
40. D.C. Alsop, W. Dai, M. Grossman, and J.A. Detre Arterial spin labeling blood flow MRI: its role in the early characterization of Alzheimer's disease J Alzheimers Dis 20 2010 871 880
41. M. Haris, A. Singh, K. Cai, C. Davatzikos, J.Q. Trojanowski, E.R. Melhem, C.M. Clark, and A. Borthakur T1rho (T1rho) MR imaging in Alzheimer' disease and Parkinson's disease with and without dementia J Neurol 258 2010 380 385
42. C.M. Clark, J.A. Schneider, B.J. Bedell, T.G. Beach, W.B. Bilker, M.A. Mintun, M.J. Pontecorvo, F. Hefti, A.P. Carpenter, and M.L. Flitter Use of florbetapir-PET for imaging beta-amyloid pathology JAMA 305 2011 275 283
43. J. Karlawish, M.S. Cary, J. Rubright, and T. Tenhave How redesigning AD clinical trials might increase study partners' willingness to participate Neurology 71 2008 1883 1888
44. J. Karlawish, J. Rubright, D. Casarett, M. Cary, T. Ten Have, and P. Sankar Older adults' attitudes toward enrollment of non-competent subjects participating in Alzheimer's research Am J Psychiatry 166 2009 182 188
45. J. Rubright, P. Sankar, D.J. Casarett, R. Gur, S.X. Xie, and J. Karlawish A memory and organizational aid improves Alzheimer disease research consent capacity: results of a randomized, controlled trial Am J Geriatr Psychiatry 18 2010 1124 1132
46. C. Ballatore, K.R. Brunden, F. Piscitelli, M.J. James, A. Crowe, Y. Yao, E. Hyde, J.Q. Trojanowski, V.M. Lee, and A.B. Smith 3rd Discovery of brain-penetrant, orally bioavailable aminothienopyridazine inhibitors of tau aggregation J Med Chem 53 2010 3739 3747
47. A. Crowe, W. Huang, C. Ballatore, R.L. Johnson, A.M. Hogan, R. Huang, J. Wichterman, J. McCoy, D. Huryn, and D.S. Auld Identification of aminothienopyridazine inhibitors of tau assembly by quantitative high-throughput screening Biochemistry 48 2009 7732 7745
48. K.R. Brunden, Y. Yao, J.S. Potuzak, N.I. Ferrer, C. Ballatore, M.J. James, A.M. Hogan, J.Q. Trojanowski, A.B. Smith 3rd, and V.M. Lee The characterization of microtubule-stabilizing drugs as possible therapeutic agents for Alzheimer's disease and related tauopathies Pharmacol Res 63 2010 341 351
49. K.R. Brunden, B. Zhang, J. Carroll, Y. Yao, J.S. Potuzak, A.M. Hogan, M. Iba, M.J. James, S.X. Xie, and C. Ballatore Epothilone D improves microtubule density, axonal integrity, and cognition in a transgenic mouse model of tauopathy J Neurosci 30 2010 13861 13866
50. B. Zhang, A. Maiti, S. Shively, F. Lakhani, G. McDonald-Jones, J. Bruce, E.B. Lee, S.X. Xie, S. Joyce, and C. Li Microtubule-binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model Proc Natl Acad Sci U S A 102 2005 227 231
51. D.W. Shineman, B. Zhang, S.N. Leight, D. Pratico, and V.M. Lee Thromboxane receptor activation mediates isoprostane-induced increases in amyloid pathology in Tg2576 mice J Neurosci 28 2008 4785 4794
52. J.Q. Trojanowski, S.E. Arnold, J.H. Karlawish, K. Brunden, M. Cary, C. Davatzikos, J. Detre, G. Gaulton, M. Grossman, and H. Hurtig Design of comprehensive Alzheimer's disease centers to address unmet national needs Alzheimers Dement 6 2010 150 155
53. R.J. Hodes Public funding for Alzheimer disease research in the United States Nat Med 12 2006 770 773